Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy

Key Clinical Message Long‐acting pasireotide and bromocriptine provided biochemical control of growth hormone and prolactin in a patient with plurihormonal pituitary macroadenoma, allowing near‐complete tumor excision while restoring pituitary function and avoiding adjunctive radiotherapy. Pasireoti...

Full description

Bibliographic Details
Main Authors: Terri W. Jerkins, Randy K. Jerkins, Robbi Franklin
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.1961
_version_ 1818265982892769280
author Terri W. Jerkins
Randy K. Jerkins
Robbi Franklin
author_facet Terri W. Jerkins
Randy K. Jerkins
Robbi Franklin
author_sort Terri W. Jerkins
collection DOAJ
description Key Clinical Message Long‐acting pasireotide and bromocriptine provided biochemical control of growth hormone and prolactin in a patient with plurihormonal pituitary macroadenoma, allowing near‐complete tumor excision while restoring pituitary function and avoiding adjunctive radiotherapy. Pasireotide initiation resulted in hyperglycemia, which stabilized after a few months and resolved upon pasireotide discontinuation (ACCESS; NCT01995734).
first_indexed 2024-12-12T19:59:28Z
format Article
id doaj.art-be137ffdadca4c1b9bb0a5938198c46d
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-12-12T19:59:28Z
publishDate 2019-03-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-be137ffdadca4c1b9bb0a5938198c46d2022-12-22T00:13:48ZengWileyClinical Case Reports2050-09042019-03-017344545110.1002/ccr3.1961Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapyTerri W. Jerkins0Randy K. Jerkins1Robbi Franklin2Midstate Endocrinology Associates Nashville TennesseeCollege of Pharmacy Lipscomb University Nashville TennesseeNashville Neurosurgery Group Nashville TennesseeKey Clinical Message Long‐acting pasireotide and bromocriptine provided biochemical control of growth hormone and prolactin in a patient with plurihormonal pituitary macroadenoma, allowing near‐complete tumor excision while restoring pituitary function and avoiding adjunctive radiotherapy. Pasireotide initiation resulted in hyperglycemia, which stabilized after a few months and resolved upon pasireotide discontinuation (ACCESS; NCT01995734).https://doi.org/10.1002/ccr3.1961endocrinologymetabolic disorderspasireotide and bromocriptine
spellingShingle Terri W. Jerkins
Randy K. Jerkins
Robbi Franklin
Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
Clinical Case Reports
endocrinology
metabolic disorders
pasireotide and bromocriptine
title Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
title_full Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
title_fullStr Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
title_full_unstemmed Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
title_short Successful debulking of plurihormonal pituitary macroadenoma with long‐acting pasireotide and dopamine agonist combination therapy
title_sort successful debulking of plurihormonal pituitary macroadenoma with long acting pasireotide and dopamine agonist combination therapy
topic endocrinology
metabolic disorders
pasireotide and bromocriptine
url https://doi.org/10.1002/ccr3.1961
work_keys_str_mv AT terriwjerkins successfuldebulkingofplurihormonalpituitarymacroadenomawithlongactingpasireotideanddopamineagonistcombinationtherapy
AT randykjerkins successfuldebulkingofplurihormonalpituitarymacroadenomawithlongactingpasireotideanddopamineagonistcombinationtherapy
AT robbifranklin successfuldebulkingofplurihormonalpituitarymacroadenomawithlongactingpasireotideanddopamineagonistcombinationtherapy